EFFICACY AND SAFETY OF USTEKINUMAB IN ASIAN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A SUBPOPULATION ANALYSIS OF UNIFI LONG-TERM EXTENSION THROUGH 3 YEARS

Tadakazu Hisamatsu  1     Hyo Jong Kim  2     Satoshi Motoya  3     Yasuo Suzuki  4     Yoshifumi Ohnishi  5     Colleen W. Marano  6     Yuya Imai  7     Carine Saadoun  8     Jianmin Zhuo  9     Shiho Kawamura  9    
1 Kyorin University School of Medicine, Tokyo, Japan
2 Kyung Hee University College of Medicine, Seoul, Korea (Republic of)
3 Sapporo-Kosei General Hospital, Hokkaido, Japan
4 Toho University Sakura Medical Center, Sakura, Japan
5 Shizuoka Medical Center, Shizuoka, Japan
6 Janssen Research & Development, LLC, Spring House
7 Janssen Pharmaceutical K.K., Tokyo, Japan
8 Janssen Pharmaceuticals Asia Pacific, Singapore, Singapore
9 Janssen China Research & Development, Shanghai

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing